Form 4: Elanco Animal Health CEO Receives Stock Grant
Insider Transaction (Form 4)
Jeffrey N Simmons, PRESIDENT, CEO AND DIRECTOR and a Director of Elanco Animal Health Inc, received 113 shares of common stock on July 24, 2026.
Summary
- Grant/award: acquired 113 Deferred Stock Units at $24.91 ($2,827) on July 24, 2026; holds 24,884 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jeffrey N Simmons — Director, Officer (PRESIDENT, CEO AND DIRECTOR)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-24 | Grant/award | Deferred Stock Units | 113.486 | $25 | $2.8K | 24,884.388 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-24 | Grant/award (113 shares) |
Keywords
insider transaction, Form 4, ELAN, Elanco Animal Health Inc, neutral, Jeffrey N Simmons
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.